City of Hope Medical Center — Duarte, California

Public research footprint of City of Hope Medical Center, compiled from the ClinicalTrials.gov public registry.

645

Registered studies

345

Active

164

Recruiting now

205

Completed

Stopped or withdrawn

Most-studied conditions

Non-Hodgkin Lymphoma · Acute Myeloid Leukemia · Myelodysplastic Syndrome · Colorectal Cancer

Recently updated registry entries

NCT06287944 — 225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and… (Recruiting)
NCT03011814 — Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory… (Recruiting)
NCT05384756 — TMLI and Alemtuzumab for Treatment of Sickle Cell Disease (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at City of Hope Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.